These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 17210612)

  • 1. A case of primary unknown carcinoma with lymphatic spread.
    Sawada M; Katsumata N
    Jpn J Clin Oncol; 2006 Dec; 36(12):827. PubMed ID: 17210612
    [No Abstract]   [Full Text] [Related]  

  • 2. Detection of unknown primary cancer with fluor-deoxy-glucose positron emission tomography.
    Jungehülsing M; Scheidhauer K; Pietrzyk U; Eckel H; Schicha H
    Ann Otol Rhinol Laryngol; 1999 Jun; 108(6):623-6. PubMed ID: 10378534
    [No Abstract]   [Full Text] [Related]  

  • 3. [A case report. FDG-PET in occult breast cancer].
    Ladjevardi S; Sörensen J; Hellman P; Juhlin C; Wärnberg F
    Lakartidningen; 2002 Feb; 99(6):524-6. PubMed ID: 11881227
    [No Abstract]   [Full Text] [Related]  

  • 4. FDG positron emission tomography to manage patients with an occult primary carcinoma and metastasis outside the cervical lymph nodes.
    TEC Bull (Online); 2002 Jul; 19(2):14-8. PubMed ID: 12166472
    [No Abstract]   [Full Text] [Related]  

  • 5. Accurate diagnosis of regional metastasis from cervical cancer: is PET the answer?
    Eifel PJ
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):637-8. PubMed ID: 15183466
    [No Abstract]   [Full Text] [Related]  

  • 6. 18F-fluoro-2-deoxy-D-glucose-positron emission tomography (PET)/PET-computed tomography in carcinoma of the cervix.
    Kumar R; Dadparvar S
    Cancer; 2007 Oct; 110(8):1650-3. PubMed ID: 17763373
    [No Abstract]   [Full Text] [Related]  

  • 7. Detection of unknown primary tumours and distant metastases in patients with cervical metastases: value of FDG-PET versus conventional modalities.
    Regelink G; Brouwer J; de Bree R; Pruim J; van der Laan BF; Vaalburg W; Hoekstra OS; Comans EF; Vissink A; Leemans CR; Roodenburg JL
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29(8):1024-30. PubMed ID: 12173016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Staging of advanced cervical cancer.
    Querleu D; Delannes M; Leblanc E; Castelain B; Sonoda Y
    Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):614. PubMed ID: 15890608
    [No Abstract]   [Full Text] [Related]  

  • 9. [Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in unknown primary neoplasms].
    Bourguet P;
    Bull Cancer; 2003 Feb; 90 Spec No():S103-4. PubMed ID: 12739342
    [No Abstract]   [Full Text] [Related]  

  • 10. 18F-FDG PET/CT in assessment of paraneoplastic cerebellar degeneration as the first sign of occult fallopian tube serous cystadenocarcinoma: Case report.
    Kalantari F; Schweighofer-Zwink G; Hecht S; Rendl G; Pirich C; Beheshti M
    Rofo; 2024 Aug; 196(8):850-851. PubMed ID: 38626884
    [No Abstract]   [Full Text] [Related]  

  • 11. [18F-FDG whole-body positron-emission tomography (PET) in patients with unknown primary tumors].
    Matheja P; Schober O
    Strahlenther Onkol; 2000 Mar; 176(3):151-2. PubMed ID: 10742838
    [No Abstract]   [Full Text] [Related]  

  • 12. 18F-FDG uptake in an ovary containing a hemorrhagic corpus luteal cyst: false-positive PET/CT in a patient with cervical carcinoma.
    Ames J; Blodgett T; Meltzer C
    AJR Am J Roentgenol; 2005 Oct; 185(4):1057-9. PubMed ID: 16177433
    [No Abstract]   [Full Text] [Related]  

  • 13. Cervical lymph node metastases of unknown origin: primary tumor detection with whole-body positron emission tomography/computed tomography.
    Nassenstein K; Veit-Haibach P; Stergar H; Gutzeit A; Freudenberg L; Kuehl H; Fischer M; Barkhausen J; Bockisch A; Antoch G
    Acta Radiol; 2007 Dec; 48(10):1101-8. PubMed ID: 17963088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implication of 18F-fluoro-2-deoxy-D-glucose positron emission tomography on management of carcinoma of unknown primary in the head and neck: a Danish cohort study.
    Johansen J; Eigtved A; Buchwald C; Theilgaard SA; Hansen HS
    Laryngoscope; 2002 Nov; 112(11):2009-14. PubMed ID: 12439171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metastatic head and neck cancer: role and usefulness of FDG PET in locating occult primary tumors.
    AAssar OS; Fischbein NJ; Caputo GR; Kaplan MJ; Price DC; Singer MI; Dillon WP; Hawkins RA
    Radiology; 1999 Jan; 210(1):177-81. PubMed ID: 9885604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detecting para-aortic lymph nodal metastasis by positron emission tomography of 18F-fluorodeoxyglucose in advanced cervical cancer with negative magnetic resonance imaging findings.
    Yeh LS; Hung YC; Shen YY; Kao CH; Lin CC; Lee CC
    Oncol Rep; 2002; 9(6):1289-92. PubMed ID: 12375036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [PET finding of primary tonsilar cancer in a man with unknown tumor].
    Gil Martínez EM; Galera Ruiz H; Moya García F; González Cabezas P
    Rev Esp Med Nucl; 2006; 25(4):263-4. PubMed ID: 16827990
    [No Abstract]   [Full Text] [Related]  

  • 18. The contribution of new imaging techniques in staging cervical cancer.
    Grigsby PW
    Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S10-2. PubMed ID: 17727940
    [No Abstract]   [Full Text] [Related]  

  • 19. 18-FDG PET-CAT scan detection of unknown primary tumor. A case report.
    Menaldo G; Rubello D; Toso S; Migliorini V; Ravasi MA
    Suppl Tumori; 2005; 4(3):S168. PubMed ID: 16437966
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of nuclear medicine in the diagnosis of cancer of unknown origin.
    Demir H; Berk F; Raderer M; Plowman PN; Lassen U; Daugaard G; Clausen M; Bohuslavizki KH; Peters M; Harmer C; Malamitsi J; Aktolun C
    Q J Nucl Med Mol Imaging; 2004 Jun; 48(2):164-73. PubMed ID: 15243411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.